| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 01/22/2009 | US20090023704 Novel Compounds 737 |
| 01/21/2009 | EP2016079A1 Polymorphs |
| 01/21/2009 | EP2016077A2 Pharmaceutical compounds |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/15/2009 | WO2009009740A1 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| 01/15/2009 | WO2008109735A3 O6-alkylguanine-dna alkyltransferase inactivators |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018148 Xanthine Derivatives, Processes For Preparing Them And Their Uses |
| 01/15/2009 | US20090018055 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/14/2009 | EP2014660A2 Novel crystalline forms of valacyclovir hydrochloride |
| 01/14/2009 | EP2014659A1 New hybrid compounds of nucleobases and organic redox molecules and their use |
| 01/14/2009 | EP2013211A2 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/14/2009 | EP2013210A1 Purine derivatives with activity to the adenosine a2a receptor |
| 01/14/2009 | EP2013199A1 Adenosine a3 receptor agonists |
| 01/14/2009 | EP2013181A1 Pyridyl compounds |
| 01/14/2009 | EP2012799A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates |
| 01/14/2009 | EP2012791A2 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
| 01/14/2009 | CN101346350A Method for production of heteroaromatic ring compound having n-rf group |
| 01/14/2009 | CN101343270A Method for extracting tea polyphenol and theine from tea simultaneously |
| 01/13/2009 | US7476727 Conjugates of mycophenolic acid |
| 01/13/2009 | US7476670 anticancer/antiproliferative activity; antifungal agents; protein kinases inhibitors in perticular Focal Adhesion Kinase inhibitors and fungal CIV1 protein kinase inhibitors; N-[6-(5,6-dichloro-2,3-dihydro-1H-indol-1-yl)-9H-purin-2-yl]-1,4-cyclohexanediamine dihydrochloride |
| 01/08/2009 | WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors |
| 01/08/2009 | WO2009005687A1 Purine derivatives and their use as modulators of toll-like receptor 7 |
| 01/08/2009 | US20090012293 Use of aryl chlorides in palladium-catalyzed c-h bond functionalization |
| 01/08/2009 | US20090012288 Process for preparation of pentostatin (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol |
| 01/08/2009 | US20090012035 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2691625A1 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 01/08/2009 | CA2691444A1 Purine derivatives and their use as modulators of toll-like receptor 7 |
| 01/07/2009 | EP2010535A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 01/07/2009 | EP2010534A1 Thioxanthine derivatives and their use as inhibitors of mpo |
| 01/07/2009 | EP2010533A2 Process for the preparation of 2,6,9-trisubstituted purines |
| 01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/07/2009 | CN101337962A Method for preparing entikawei |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473780 Drying process for preparing crystalline solid famciclovir |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/01/2009 | US20090005560 Production method of diaminopyrimidine compounds |
| 01/01/2009 | US20090005400 Biologically Active Aphrocallistin Compounds |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 12/31/2008 | WO2008122767A3 2, 6, 9-substituted purine derivatives having anti proliferative properties |
| 12/31/2008 | EP2009003A1 Production method of diaminopyrimidine compounds |
| 12/31/2008 | EP2008210A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 12/31/2008 | EP2007766A1 Narcotine purification process |
| 12/31/2008 | CN100447149C COMT inhibitors |
| 12/31/2008 | CN100447143C Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
| 12/30/2008 | US7470696 Tyrosine kinase inhibitors |
| 12/30/2008 | CA2298059C Nucleotide analog composition and synthesis method |
| 12/29/2008 | CA2636734A1 Metal coordinated compositions |
| 12/25/2008 | US20080319005 Phenylacetamides Suitable as Protein Kinase Inhibitors |
| 12/24/2008 | WO2008155613A1 An improved process for preparing purine derivative |
| 12/24/2008 | WO2008115262A3 Hsp90 inhibitors containing a zinc binding moiety |
| 12/24/2008 | EP2004648A1 Purine compounds as hsp90 protein inhibitors for the treatment of cancer |
| 12/24/2008 | CN101331133A Sulphonamidoaniline derivatives being Janus kinases inhibitors |
| 12/23/2008 | US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 12/18/2008 | WO2008153947A2 Heterocyclic compounds as raf kinase modulators |
| 12/18/2008 | WO2008152420A1 New compounds 892 |
| 12/18/2008 | CA2694871A1 Chemical compounds |
| 12/18/2008 | CA2690468A1 New compounds 892 |
| 12/17/2008 | EP2001881A2 Compositions and methods for treating respiratory disorders |
| 12/17/2008 | EP2001877A1 Method for extracting target alkaloid using an ionic liquid as extracting solvent |
| 12/17/2008 | EP2001488A2 Prevention and treatment of cancer and other diseases |
| 12/11/2008 | WO2008148560A1 New hybrid compounds of nucleobases and organic redox molecules and their use |
| 12/11/2008 | WO2008120205B1 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents |
| 12/11/2008 | US20080305557 Novel Applications of Acridinium Compounds and Derivatives in Homogeneous Assays |
| 12/10/2008 | EP1999132A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity |
| 12/10/2008 | EP1720875B1 8- [3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments |
| 12/10/2008 | EP1387819B1 Hydrogenation processes performed in ionic liquids |
| 12/04/2008 | WO2008024277A3 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 12/04/2008 | WO2007092496A3 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
| 12/04/2008 | US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV |
| 12/04/2008 | US20080300244 Novel compounds |
| 12/04/2008 | US20080299556 Alkylguanyltransferase Assays |
| 12/03/2008 | EP1996593A2 Pharmaceutically acceptable salts and polymorphic forms |
| 12/03/2008 | CN101314603A Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof |
| 12/03/2008 | CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 12/03/2008 | CN100439369C Purine compounds and use thereof as cannabinoid receptor ligands |
| 12/02/2008 | US7459479 Benzylated PDE4 inhibitors |
| 12/02/2008 | US7459454 Aminopyrazine derivatives and compositions |
| 12/02/2008 | CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/02/2008 | CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance |
| 11/27/2008 | WO2008143846A1 Azido purine nucleosides for treatment of viral infections |
| 11/27/2008 | WO2008143674A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
| 11/27/2008 | WO2008141455A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 11/27/2008 | WO2008121742A3 Inhibitors of bruton's tyrosine kinase |
| 11/27/2008 | WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 11/27/2008 | WO2008024438A3 2-phenoxy pyrimidinone analogues |
| 11/27/2008 | US20080293938 Novel Process for the Preparation of Didanosine Using Novel Intermediates |
| 11/27/2008 | US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors |
| 11/27/2008 | US20080293747 Chemical Synthesis of a Highly Potent Epothilone |
| 11/27/2008 | US20080293705 A1 adenosine receptor antagonists |
| 11/27/2008 | US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors |
| 11/27/2008 | CA2687338A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 11/27/2008 | CA2686485A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
| 11/26/2008 | CN100438211C Method and unit for beam control of antenna array |
| 11/26/2008 | CN100436452C Pyrazole compounds useful as protein kinase inhibitors |
| 11/25/2008 | US7456282 Famciclovir intermediate; reaction with diethyl malonate, reduction, esterification with acetic anhydride |
| 11/25/2008 | US7456206 Biaryl heterocyclic compounds and methods of making and using the same |
| 11/25/2008 | CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |